Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityOther Accumulated ExpensesPayablesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Marker Therapeutics (MRKR) Liabilities from Discontinued Operations (2022 - 2023)

Marker Therapeutics (MRKR) has disclosed Liabilities from Discontinued Operations for 1 consecutive years, with 7039338.0 as the latest value for Q4 2022.

  • On a quarterly basis, Liabilities from Discontinued Operations changed N/A to 7039338.0 in Q4 2022 year-over-year; TTM through Dec 2022 was 7039338.0, a N/A change, with the full-year FY2022 number at 7039338.0, changed N/A from a year prior.
  • Liabilities from Discontinued Operations was 7039338.0 for Q4 2022 at Marker Therapeutics.
  • In the past five years, Liabilities from Discontinued Operations ranged from a high of 7039338.0 in Q4 2022 to a low of 7039338.0 in Q4 2022.